ADP:ATP Cancer Research Results

ADP:ATP, ADP/ATP ratio: Click to Expand ⟱

Source:

Type:

ADP/ATP ratio is a key indicator of a cell’s energy state and mitochondrial function. In the context of cancer, shifts in the ADP/ATP ratio reflect changes in metabolic activity, mitochondrial efficiency, and overall cellular bioenergetics.
The ADP/ATP ratio reflects the balance between energy consumption and production. A high ADP/ATP ratio indicates lower energy reserves (or higher energy consumption), while a low ratio suggests abundant ATP availability.
• Mitochondrial Function and Metabolism:
– Cancer cells often reprogram their metabolism (the “Warburg effect”) to favor glycolysis even in the presence of oxygen. This metabolic shift can affect the ADP/ATP ratio.
– Mitochondrial dysfunction, commonly observed in tumors, may also lead to altered ADP/ATP ratios, impacting how cells respond to metabolic stress.

• Elevated ADP/ATP Ratio:
– In some aggressive tumors, an elevated ADP/ATP ratio can be a sign of mitochondrial stress or increased energy turnover.
– This state may result from rapid proliferation, increased energy demand, or inefficient ATP production.

• Reduced ADP/ATP Ratio:
– Alternatively, some cancer cells may maintain a lower ADP/ATP ratio by upregulating glycolysis or oxidative phosphorylation, ensuring a steady ATP supply to fuel growth and survival.
– Tumors with a robust bioenergetic capacity may display lower ratios, possibly correlating with resistance to energetic stress.

An elevated or imbalanced ADP/ATP ratio has been associated with aggressive tumor behavior and may predict poor prognosis in certain contexts, although its exact role can vary by tumor type.

CLL, Chronic Lymphocytic Leukemia: Click to Expand ⟱

CLL is a type of cancer that affects the lymphoid cells, which are a type of white blood cell. It is characterized by the accumulation of mature, but dysfunctional, lymphocytes in the bone marrow, lymph nodes, and spleen. CLL is typically a slow-growing disease, and many patients may not experience symptoms for years after diagnosis.

Scientific Papers found: Click to Expand⟱

1249-

CHr,

Chrysin as an Anti-Cancer Agent Exerts Selective Toxicity by Directly Inhibiting Mitochondrial Complex II and V in CLL B-lymphocytes

in-vitro,

CLL,

ROS↑, MMP↓, ADP:ATP↑, Casp3↑, Apoptosis↑,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:

Redox & Oxidative Stress ⓘ

ROS↑, 1,

Mitochondria & Bioenergetics ⓘ

ADP:ATP↑, 1, MMP↓, 1,

Cell Death ⓘ

Apoptosis↑, 1, Casp3↑, 1,
Total Targets: 5

Pathway results for Effect on Normal Cells:

Total Targets: 0

Scientific Paper Hit Count for: ADP:ATP, ADP/ATP ratio

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells